Predicting and preventing heart disease.
Bodyport is a virtual cardiac clinic aimed at reducing the burden of heart disease through personalized, evidence-based care. In just one daily step, our novel sensors and algorithms predict changes in health status, enabling early, optimized interventions that significantly improve outcomes. Bodyport is initially targeting heart failure, a chronic condition affecting over 6 million Americans and a leading cause of hospitalizations (1M/year) and healthcare spending ($35B/year). Bodyport is backed by leading investors including Initialized Capital, Playground Global, Boehringer Ingelheim, Y Combinator, and Rock Health.
As Chief Medical Officer, you will help ensure Bodyport’s product and commercial strategies are guided by sound clinical insight and rigorous scientific validation. You will represent Bodyport in the medical and scientific community through research publications and presentations and be a leading voice for the product among providers and payers. You will provide oversight of clinical strategy, helping to drive the science that makes Bodyport the standard of care. You will help inform the development of Bodyport’s virtual care services, driving improved outcomes and facilitating the shift toward value-based healthcare.
Your role at Bodyport:
You'd be a fit if you have:
We want you to know
You can be a great candidate even if you don't fit everything we've described above. You can also have important skills we haven't thought of. If that's you, don't hesitate to apply and tell us about yourself (especially in your cover letter - this is where you can really state your case for why you).
We are committed to diversity and building an equitable and inclusive environment for people of all backgrounds and experiences, and we're taking steps to meet that commitment. We especially encourage members of traditionally underrepresented communities to apply, including women, people of color, LGBTQ people, veterans, and people with disabilities.
Bodyport is building a virtual cardiac clinic to help keep patients with heart disease healthy and in their homes. The clinic is built around our novel cardiovascular sensing scale and predictive algorithms that detect early subclinical changes in cardiac function. We’re initially targeting heart failure, a chronic condition affecting over 6M Americans and a leading cause of hospitalizations (1M/year) and healthcare spending ($35B/year).